Cargando…

On the synergy between silver nanoparticles and doxycycline towards the inhibition of Staphylococcus aureus growth

In a previous paper (RSC Adv., 2015, 5, 66886–66893), we showed that the combination of silver nanoparticles (NanoAg) with doxycycline (DO) culminated in an increased bactericidal activity towards E. coli. Herein we further investigated the metabolic changes that occurred on Staphylococcus aureus up...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Heloiza F. O., de Lima, Rayane P., da Costa, Fernanda S. L., Moraes, Edgar P., Melo, Maria C. N., Sant’Anna, Celso, Eugênio, Mateus, Gasparotto, Luiz H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081745/
https://www.ncbi.nlm.nih.gov/pubmed/35540305
http://dx.doi.org/10.1039/c8ra02176g
Descripción
Sumario:In a previous paper (RSC Adv., 2015, 5, 66886–66893), we showed that the combination of silver nanoparticles (NanoAg) with doxycycline (DO) culminated in an increased bactericidal activity towards E. coli. Herein we further investigated the metabolic changes that occurred on Staphylococcus aureus upon exposure to NanoAg with the help of attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) coupled with multivariate data analysis. It has been discovered that the combination of DO with NanoAg produced metabolic changes in S. aureus that were not simply the overlap of the treatments with DO and NanoAg separately. Our results suggest that DO and NanoAg act synergistically to impede protein synthesis by the bacteria.